Recent clinical issues related to the use of depot medroxyprogesterone acetate (Depo-Provera).
This report critically reviews recent original research articles concerning patient use of depot medroxyprogesterone acetate. Specifically, recent studies have been conducted on the following clinical issues: depression, galactorrhea, weight gain, bone mineral density, epithelial and mucus changes in the lower genital tract, and the acceptability of and continuation rates with the use of depot medroxyprogesterone acetate.
Cromer
B A
BA
College of Medicine and Public Health, The Ohio State University, Columbus, USA. bcromer@metrohealth.org
D015519:Bone Density / Q000187:drug effects; D003271:Contraceptive Agents, Female / Q000009:adverse effects*; D005260:Female; D005687:Galactorrhea / Q000139:chemically induced; D006801:Humans; D017258:Medroxyprogesterone Acetate / Q000009:adverse effects*; D017060:Patient Satisfaction; D015430:Weight Gain / Q000187:drug effects
D003271:Contraceptive Agents, Female; D017258:Medroxyprogesterone Acetate